FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Nevirapine (Viramune) Extended Release Tablets
Status: Discontinuation
»Therapeutic Categories: Antiviral

Boehringer Ingelheim Pharmaceuticals, Inc. (New 07/21/2017)

Company Contact Information:

Presentation Posting Date Related Information
Viramune XR (nevirapine) extended release 100mg tablets (NDC 0597-0129-90) 07/21/2017 Viramune XR (nevirapine) extended release 400mg tablets will continue to be manufactured.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English